Company Overview and News

13
7 Alternative Internet of Things Stocks to Buy

14h investorplace
As an investment sector, the Internet of Things, or IoT, is a no-brainer. Increasingly, our consumer devices no longer have a specific function or operation; rather, they’re part of an integrated, digital ecosystem that responds to variable requests. This movement will only increase in volume and engagement, but picking the right IoT stock can be a challenge.
ADT FIT HON MU GRMN AAPL ADI EMR JCI INTC NTGR

21
John And Jane: June Dividend Income Tracker - Taxable Account

2018-07-16 seekingalpha
June marks the eighth month I have officially tracked the taxable account's dividend income. The total amount of dividend income received was $676.96.
SOJA ETP.PRC GIS XOM IDCC EPR.PRG O.PRF SKT LTC OPRF BPL SEP COP MIC CINF AAPL CAH EMR BBT SO TLP WLK O MSB OZRK CMI ETP SPG.PRJ HP ORI SPG WPC ADM

17
The World Cup of Dividend Stocks: 8 of the Most Dependable Dividends

2018-07-16 investorplace
The World Cup began in 1930. After a 12-year break due to World War II, the soccer — oops, fútbol — tournament has been played every four years since 1950. This weekend we watched France beat Croatia 4-2 to win the 2018 World Cup. But it got us thinking, what about a World Cup for dividend stocks?
LOW PG PH AWR GPC NYTAB CL JNJ NWN KO DOV EMR MMM

82
Retirement Income (Part 2): I Am Building A Retirement Income Fund - Here Is What I Am NOT Doing

2018-07-02 seekingalpha
In the first article of this series, the current interest rate environment was described as it impacts significantly long-term investments being made today in that environment.
LOW FRT SPG.PRJ JNJ ADP KO BEN GPC EMR SPG ED MCD

211
7 Stocks to Buy That Aren’t in the Dow But Should Be | InvestorPlace

2018-06-28 investorplace
There were 12 companies in the original Dow Jones Industrial Average when it got its start in 1896. General Electric (NYSE:GE) was one of them. Today’s it no longer is.
GE GEC TRV PSX WBA PGR ZTS GOOG ATVI BRK.A AMZN GOOGL GNE SBUX EMR ABAX

1
EMR / Emerson Electric Co. 8-K (Current Report)

2018-06-21 sec.gov
Document UNITED STATES
EMR

55
Under Armour Is A Winner - Cramer's Lightning Round (6/20/18)

2018-06-21 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, June 20.
PFPT NVCR CGNX UAA PANW WTW CHGG CYBR UA FEYE EMR BMY ROK

20
7 Stocks That Could Take a Trade-War Hit

2018-06-14 investorplace
Chrystia Freeland, Canada’s Minister of Foreign Affairs, who is also responsible for Canada’s NAFTA negotiations, accepted Foreign Policy’s 2018 award for Diplomat of the Year on June 13. As she accepted the award, she reminded the audience that a trade war between Canada and the U.S. has no winners, not even President Trump.
WHR GM.WS.A GM.WS.B GM.WS.C SBUX EMR GM TRN FIZZ GM.WSB MAS

0
EMR / Emerson Electric Co. FORM 8-K (Current Report)

2018-06-11 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
EMR

316
John And Jane: May Dividend Income Tracker - Taxable Account

2018-06-11 seekingalpha
This is the seventh month I have officially tracked the taxable account's dividend income, and it was slightly below expectations with a total of $1,642.46 of dividends received.
SOJA ETP.PRC GIS EBGUF XOM IDCC EPR.PRG O.PRF SKT LTC ENB OPRF BPL SEP COP MIC CINF AAPL CAH EMR EEP SO TLP WLK O MSB CMI WLKP ENB ETP SPG.PRJ HP PEP ORI SPG WPC ADM

9
Valero Energy Is A Buy - Cramer's Lightning Round (6/4/18)

2018-06-05 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, June 4.
HEP MNST EMR VLO MPC PRGS FANG

0
EMR / Emerson Electric Co. SD

2018-05-31 sec.gov
SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
EMR

0
EMR / Emerson Electric Co. 8-K (Current Report)

2018-05-29 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
EMR

0
EMR / Emerson Electric Co. 8-K (Current Report)

2018-05-23 sec.gov
Document UNITED STATES
EMR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EMR / Emerson Electric Co. on message board site Silicon Investor.

Emerson (EMR) Emgold-Lang Mining Group
EMRG - Emerge Interact EMRG: Emerge Interactive
EMRI - UP UP u0026 AWAY EMR Microwave Technology (EMW.A)
Femrx(fmrx)
CUSIP: 291011104